Yanyan Jia

Yanyan Jia

Auto-generated profile, based on publicly available information

Yanyan Jia

School of Integrative Biological and Chemical Sciences, University of Texas Rio Grande Valley, Brownsville, TX 78520, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Inorganic Chemistry Communications
Verified
Journal Article
Closed access
NZNa Zhang
Na Zhang
BLBin Liu
Bin Liu
XLXuemei Liu
Xuemei Liu
TDTuo Ding
Tuo Ding
YJYing Jia
Ying Jia
GXGanglin Xue
Ganglin Xue

1 December 2017 in Int. Journal of Clinical Pharmacology and Therapeutics
Verified
Journal Article
Closed access
YSYing Song
Ying Song
YDYi Ding
Yi Ding
YJYing Jia
Ying Jia
JZJinyi Zhao
Jinyi Zhao
KGKai Gao
Kai Gao
AWAidong Wen
Aidong Wen
Zaltoprofen, a propionic acid derivative of nonsteroidal anti-inflammatory drug (NSAID), has powerful anti-inflammatory and analgesic effects on inflammatory pain. This study was undertaken to investigate the effect of food on the pharmacokinetic parameters of zaltoprofen capsule (trial preparation, T) and tablet (reference preparation, R), and to assess the relative bioequivalence of two zaltoprofen preparations. In this open-label, randomized, crossover, two-state, four-period study, 24 healthy Chinese volunteers were randomized to receive a single oral dose of zaltoprofen capsule/tablet (80 mg) under fasting and fed state. Plasma samples were obtained for 24 hours and measured by a developed LC-MS/MS method. Pharmacokinetic parameters were calculated using noncompartmental analysis. Safety and tolerability were assessed throughout the study. 24 healthy participants received two zaltoprofen preparations. For zaltoprofen capsule and tablet, coadministration of high-fat food significantly decreased Cmax by 23 and 22%, respectively; tmax was prolonged by 0.7 hours and 0.8 hours, while the AUClast (for T, geometric mean ratio (GMR): 101.81%, 90% confidence interval (CI): 94.71 - 108.14%; for R, GMR: 101.02%, 90% CI: 93.78 - 107.12%) was not significantly affect by the food. Under fasting or fed condition, the 90% CI of T/R ratios of the geometric means for the primary pharmacokinetic parameters AUC and Cmax were within the acceptance range of 80 - 125%. These data suggest that the absorption of zaltoprofen is delayed by high-fat-food administration while total exposure is not affected. The two zaltoprofen preparations (capsule and tablet) are bioequivalent under fasting and fed state. .

1 October 2012 in Biological Rhythm Research
Verified
Journal Article
Closed access
YDYi Ding
Yi Ding
YJYing Jia
Ying Jia
WLWenXing Liu
WenXing Liu
CLChengTao Lu
ChengTao Lu
YZYanRong Zhu
YanRong Zhu
AWAidong Wen
Aidong Wen
Few researches were conducted on the circadian variation of β-lactam antibiotics in humans. The aim of the present study was to determine whether circadian variation of cefalexin pharmacokinetics exists in postprandial or fasting male volunteers. Cefalexin was given orally to subjects under postprandial conditions or after an 8-h fast, at 08:00 or 20:00 h. In experiment 1, after the oral dose under postprandial conditions, time-dependent changes in cephalexin pharmacokinetics were significant. The elimination half-life (t 1/2) was prolonged obviously and thepeak serum concentration (C max) was higher after the 20:00 h compared to the 08:00 h administration. However, in experiment 2, no significant differences were found in the main pharmacokinetic parameters of cephalexin administered at two occasions after fasting. It is concluded that in this study, time of administration may affect the pharmacokinetics of cephalexin under the postprandial condition, and fasting may suppress the diurnal variations in cefalexin pharmacokinetics.

1 January 2014 in Chinese Journal of Chromatography
Verified
Journal Article
Closed access
YJYing Jia
Ying Jia
JTJianhua Tan
Jianhua Tan
CXChen Xu
Chen Xu
JTJiajun Tang
Jiajun Tang
YWYingli Wang
Yingli Wang
QXQilai Xie
Qilai Xie
An analytical method has been developed and validated for the simultaneous determination of nine pharmaceuticals and personal care products (PPCPs) in water samples, including salicylic acid, naproxen, ibuprofen, paracetamol, clofibric acid, triclosan, diclofenac, ketoprofen, bisphenol A. The qualification and quantification of the target compounds were performed by gas chromatography-mass spectrometry in selected ion monitoring mode (GC-MS-SIM). The water samples were concentrated and purified through Oasis HLB cartridges after the pH value of the water was adjusted to 3, then derivatized with trimethyl sulfonium hydroxide (TMSH) at room temperature, and determined by GC-MS-SIM using 2,4,5-fenoprop as internal standard. The conditions for sample pretreatment (e. g. solid phase extraction and derivatization) were studied. Under the optimized conditions, the recoveries were ranged from 50.7% to 115.4% with the relative standard deviations lower than 10%. The limits of detection were in the range of 0.03-0.30 microg/L and the limits of quantification were in the range of 0.15-1.50 microg/L. The method has been successfully applied to monitor the occurrence of the PPCPs residues in agricultural irrigation water in Dongguan, Guangdong Province. The four compounds were detected at maximum mass concentration range of 0.176-0.998 microg/L. It proved that this analytical method is sensitive, reliable and acceptable.

24 January 2025 in Toxins
Verified
Journal Article
Open access
PDF file
YJYing Jia
Ying Jia
AGAriane Garcia
Ariane Garcia
ERElizabeth Reyes
Elizabeth Reyes
Snakebite is a critical global public health issue, causing substantial mortality and morbidity, particularly in tropical and subtropical regions. The development of innovative antivenoms targeting snake venom toxins is therefore of paramount importance. In this study, we adopted an epitope-directed approach to design three degenerate 15-mer peptides based on amino acid sequence alignments of snake venom phospholipase A2s (PLA2s) and snake venom serine proteases (SVSPs) from snake (Crotalus atrox). By leveraging their immunogenic and inhibitory profiles, these peptides were specifically designed to target the Asp49 and Lys49 variants of PLA2 and SVSP toxins. Groups of five mice were immunized with each peptide, and IgG mRNA was subsequently extracted from peripheral blood mononuclear cells (PBMCs) and spleen lymphocytes of the top three responders. The extracted mRNA was reverse-transcribed into complementary DNA (cDNA), and the variable regions of the IgG heavy and kappa chains were amplified using polymerase chain reaction (PCR). These amplified regions were then linked with a 66-nucleotide spacer to construct single-chain variable fragments (scFvs). Sequence analysis of 48 randomly selected plasmids from each PLA2 and SVSP scFv library revealed that over 80% contained scFv sequences with notable diversity observed in the complementarity-determining regions (CDRs), particularly CDR3. Enzyme-linked immunosorbent assay (ELISA) results demonstrated that the SP peptide elicited a broader immune response in mice compared to the Asp49 peptide, implying the strong immunogenicity of the SP peptide. These scFvs represent a promising foundation for the development of recombinant human monoclonal antibodies targeting snake PLA2 and SVSP toxins, providing a potential therapeutic strategy for the treatment of snakebites.